Ingelfinger, MD, from @tuftsmedschool and the Maine Medical Center Institute for Research: nejm.org/doi/full/10.10 GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure
Liam Swain is a MSc student at the University of Calgary, specializing in the epidemiology of alcohol-related liver disease
It also includes information on more than 790,000 prescribing providers by NPI making it one of the most comprehensive GLP-1 analytics sources available today
Arthritis affects over 58 million Americans, and excess weight amplifies joint damage and inflammation
6509) was introduced in Congress, aiming to tighten federal oversight of compounding and outsourcing facilities
Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six teratology information services